文献速递眼底病与葡萄膜炎

新生血管性年龄相关性黄斑变性治疗眼中医师分级视网膜下纤维化的患病率与危险因素

PREVALENCE AND RISK FACTORS FOR THE DEVELOPMENT OF PHYSICIAN-GRADED SUBRETINAL FIBROSIS IN EYES TREATED FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
PubMed 文献 · Retina · 2020-01-01

基于新生血管性年龄相关性黄斑变性(nAMD)注册研究数据,对接受血管内皮生长因子抑制剂治疗最长10年的眼进行横断面与纵向分析。视网膜下纤维化(SRFi)患病率从0-1年间的20.4%升至9-10年间的40.7%,基线视力差、病灶大、以经典型为主及高活动比例是独立相关因素。

要点

  • SRFi患病率随治疗年限从0-1年的20.4%升至9-10年的40.7%。
  • 基线视力≤35字母、病灶较大、以经典型为主及高活动比例与SRFi独立相关。
  • 10年治疗中约40%眼出现SRFi,提示长期随访中需关注纤维化进展。

核心结论

  • 在接受血管内皮生长因子抑制剂治疗最长10年的nAMD眼中,视网膜下纤维化在10年后见于40%的眼。

研究设计与样本

  • 对nAMD注册研究数据进行横断面与纵向分析,SRFi的存在与位置由治疗医师分级,共纳入2,914眼评估患病率。

主要发现

  • 患病率从年区间0-1的20.4%升至年区间9-10的40.7%。
  • 1,950眼的发病率在基线为14.3%,24个月时为26.3%。
  • 与SRFi独立相关的特征包括基线视力较差(视力≤35字母 vs ≥70字母,校正OR 5.33,95%CI 4.66-7.61,P<0.01)。
  • 基线病灶大小(每1000 µm校正OR 1.08,95%CI 1.08-1.14,P=0.03)、病灶类型(以经典型为主 vs 隐匿性,校正OR 1.42,95%CI 1.17-1.72,P=0.02)及活动访视比例(最高活动组 vs 最低活动组,校正OR 1.58,95%CI 1.25-2.01,P<0.01)亦与SRFi独立相关。

临床怎么用

  • 对基线视力差、病灶较大、以经典型为主或活动访视比例高的nAMD患者,长期治疗中应关注视网膜下纤维化的发生。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To assess the prevalence and incidence of and risk factors for subretinal fibrosis (SRFi) in eyes with neovascular age-related macular degeneration (nAMD) that underwent vascular endothelial growth factor inhibitor treatment for up to 10 years. METHODS: A cross-sectional and longitudinal analysis was performed on data from a neovascular age-related macular degeneration registry. The presence and location of SRFi were graded by the treating practitioner. Visual acuity, lesion characteristics (type, morphology, and activity), and treatment administered at each visit was recorded. RESULTS: The prevalence of SRFi in 2,914 eyes rose from 20.4% at year interval 0-1 to 40.7% at year interval 9 to 10. The incidence in 1,950 eyes was 14.3% at baseline and 26.3% at 24 months. Independent characteristics associated with SRFi included poorer baseline vision (adjusted odds ratio 5.33 [95% confidence interval 4.66-7.61] for visual acuity ≤35 letters vs. visual acuity ≥70 letters, P < 0.01), baseline lesion size (adjusted odds ratio 1.08 [95% confidence interval 1.08-1.14] per 1000 µm, P = 0.03), lesion type (adjusted odds ratio 1.42 [95% confidence interval 1.17-1.72] for predominantly classic vs. occult lesions, P = 0.02), and proportion of active visits (adjusted odds ratio 1.58 [95% confidence interval 1.25-2.01] for the group with the highest level of activity vs. the lowest level of activity, P < 0.01). CONCLUSION: Subretinal fibrosis was found in 40% of eyes after 10 years of treatment. High rates of lesion activity, predominantly classic lesions, poor baseline vision, and larger lesion size seem to be independent risk factors for SRFi.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Teo KYC, Joe AW, Nguyen V, et al. PREVALENCE AND RISK FACTORS FOR THE DEVELOPMENT OF PHYSICIAN-GRADED SUBRETINAL FIBROSIS IN EYES TREATED FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Retina. 2020. PMID: 32073543. doi:10.1097/IAE.0000000000002779

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。